Keywords: Hi-Tech Pharmacal, Cormax, Watson Pharma, branded versions of clobetasol, Dermatoses

Hi-Tech Pharmacal gains rights to the Cormax brand from Watson

Article | 05 June 2012

Hi-Tech Pharmacal (Nasdaq: HITK) says it has signed a definitive agreement under which it has acquired exclusive rights to the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in